Private Wealth Management Group, LLC Avidity Biosciences, Inc. Transaction History
Private Wealth Management Group, LLC
- $231 Billion
- Q2 2024
A detailed history of Private Wealth Management Group, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 78 shares of RNA stock, worth $3,155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78
Previous 78
-0.0%
Holding current value
$3,155
Previous $1.99 Million
60.07%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RNA
# of Institutions
206Shares Held
95.5MCall Options Held
171KPut Options Held
196K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$442 Million0.05% of portfolio
-
Rtw Investments, LP New York, NY8.81MShares$356 Million6.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$349 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.51MShares$263 Million3.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.94MShares$240 Million0.0% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.11B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...